CSL doubles manufacturing capacity

CSL Biotherapies, a subsidiary of CSL Limited Australia and one of the world’s leading manufacturers of influenza vaccine, has announced it has been awarded a contract by the United States Department of Health Services to supply pre-pandemic and pandemic vaccine antigens and related services to the U.S. national stockpile.
Read More